12th September 2024

MediWales Member Named as a Finalist in the OBN Awards

One of MediWales’ members, Ambrose Healthcare, has recently been named as a finalist in the OBN Awards 2024 for the Best Start-Up Biotech Company.

The OBN Awards celebrate exceptional innovation, leadership and contribution in the life sciences industry. Their Best Start-Up Biotech Company category shines a spotlight on early stage UK companies that are making significant strides within the industry. This highlights Ambrose Healthcare’s commitment to addressing unmet clinical needs through their approach to developing treatments for rare diseases.

Ambrose Healthcare are a pharmaceutical start-up who are addressing the global need for rare disease treatments. With only 5-10% of rare diseases having an FDA-approved treatment, Ambrose is on a mission to get safe and effective therapies onto the market and into the hands of patients quickly and cost effectively.

The winners of the OBN Awards 2024 will be announced at the awards ceremony in London on the 20th November.

To find out more about Ambrose Healthcare’s success, click here.